(Q34557270)

English

Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

chronic obstructive pulmonary disease

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Thierry Troosters

4

object named as

Thierry Troosters

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1

object named as

Marc Decramer

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

P N Richard Dekhuijzen

3

object named as

P N Richard Dekhuijzen

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Maureen Rutten-van Mölken

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Cees van Herwaarden

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Riccardo Pellegrino

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

C P Onno van Schayck

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Dario Olivieri

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Mario Del Donno

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Wilfried De Backer

10

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Ida Lankhorst

11

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Alfredo Ardia

12

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

1 April 2005

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

365

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

9470

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1552-1560

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Oxidative Stress in Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Exhaled Carbon Monoxide and Nitric Oxide in COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The Bronchitis Randomized On NAC Cost-Utility Study (BRONCUS): hypothesis and design. BRONCUS-trial Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

EuroQol: the current state of play

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cox's Regression Model for Counting Processes: A Large Sample Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing the reversibility of airway obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Time course of recovery of health status following an infective exacerbation of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The intrabronchial microbial flora in chronic bronchitis patients: a target for N-acetylcysteine therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of bacterial adherence to ciliated and squamous epithelial cells obtained from the human respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966456-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(05)66456-2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34557270&oldid=1833566257"